fashion -WSS

fashion

author：Wikipedia 2025-09-06 04:51:35 - browse：71341

a liver made up by geometric shapes – biotech coverage from STAT — Adobe

LONDON — A drug in development as a weight loss treatment succeeded in a Phase 2 study in a serious liver condition, its developers said Monday, as the competition in the broader obesity medicine field pushes ahead.

The drug, survodutide, is being developed by the privately held German firm Boehringer Ingelheim and the Danish biotech Zealand Pharma. Zealand’s share price has doubled over the past year over the potential of the drug, and on Monday morning, shares jumped another 25%.

In the study, 83% of patients with a condition called MASH and who were treated with survodutide saw significant improvements in their disease compared to 18% of those who received placebo. The study met its primary endpoint of improvements in MASH after 48 weeks without the worsening of fibrosis, a scarring of the liver, the companies said. Secondary endpoints were also met, including an improvement in fibrosis.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Novavax promises a turnaround & Lilly roils the obesity market
Next article： Psilocybin's anti

leisure time

WSS

AstraZeneca challenges Medicare drug negotiation program

AstraZeneca bets AAV gene therapy will still deliver the goods

Appeals court upholds limits to abortion pill

Myanmar's Supreme Court hears arguments in 2 appeals by ousted leader Aung San Suu Kyi

Winners, losers from Medicare’s list of drugs subject to price talks

Neuroscience startup Neumora files for IPO

hotspot

fashion

leisure time

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

How Long Island became the ‘eugenics capital of the world’

Jerome Adams on the need for new antivirals for Covid

EU moves toward latest gene techniques in food production to counter climate change, shortages

Alkermes shareholders re

Australia’s approach to dialysis celebrates life

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Complete sequence of Y chromosome published for first time

As demand for Covid shots wanes, Moderna seeks its next success

1 in 4 Americans hadn't contracted COVID by the end of 2022, CDC estimates

explore

Medicare explains how it will choose drugs for negotiation

Study finds new variant for Parkinson’s in African populations

Australia’s approach to dialysis celebrates life

Complete sequence of Y chromosome published for first time

Psilocybin's anti

How a symptom of dementia informs our understanding of creativity

knowledge

explore

leisure time

entertainment